KCM Investment Advisors LLC Has $897,000 Stock Holdings in Intuitive Surgical, Inc. $ISRG

KCM Investment Advisors LLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 50.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,651 shares of the medical equipment provider’s stock after selling 1,676 shares during the quarter. KCM Investment Advisors LLC’s holdings in Intuitive Surgical were worth $897,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. Nuveen LLC bought a new stake in Intuitive Surgical during the first quarter worth $1,715,899,000. Goldman Sachs Group Inc. increased its stake in shares of Intuitive Surgical by 26.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock worth $1,396,496,000 after purchasing an additional 584,375 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Intuitive Surgical by 20.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock valued at $1,680,922,000 after purchasing an additional 566,979 shares during the period. Jennison Associates LLC lifted its stake in Intuitive Surgical by 20.4% in the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock valued at $1,696,738,000 after purchasing an additional 528,359 shares during the last quarter. Finally, Wellington Management Group LLP lifted its stake in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after purchasing an additional 457,080 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ISRG. Argus raised their price objective on Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Piper Sandler boosted their target price on Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Rothschild & Co Redburn raised their price target on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Daiwa Capital Markets lifted their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, October 31st. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $608.92.

Intuitive Surgical Stock Performance

ISRG opened at $560.00 on Friday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The firm has a market cap of $200.75 billion, a P/E ratio of 74.07, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. The business’s fifty day moving average is $471.89 and its 200-day moving average is $501.02.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.84 earnings per share. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the transaction, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. This represents a 9.47% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Craig H. Barratt sold 2,193 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $548.01, for a total transaction of $1,201,785.93. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 98,078 shares of company stock valued at $51,445,892. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.